Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$247.84 - $340.0 $77,821 - $106,760
-314 Reduced 19.01%
1,338 $449,000
Q4 2023

Feb 06, 2024

BUY
$222.83 - $285.76 $17,380 - $22,289
78 Added 4.96%
1,652 $467,000
Q3 2023

Nov 03, 2023

SELL
$236.44 - $265.62 $12,058 - $13,546
-51 Reduced 3.14%
1,574 $387,000
Q2 2023

Aug 04, 2023

SELL
$183.12 - $250.2 $7,691 - $10,508
-42 Reduced 2.52%
1,625 $406,000
Q1 2023

May 01, 2023

BUY
$193.59 - $245.33 $41,428 - $52,500
214 Added 14.73%
1,667 $356,000
Q4 2022

Feb 07, 2023

BUY
$173.9 - $224.8 $252,676 - $326,634
1,453 New
1,453 $282,000

Others Institutions Holding ICLR

About ICON PLC


  • Ticker ICLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 81,526,600
  • Market Cap $17.4B
  • Description
  • ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development proces...
More about ICLR
Track This Portfolio

Track Lincoln National Corp Portfolio

Follow Lincoln National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.